期刊文献+

lncRNA EGFR-AS1靶向miR-577对卵巢癌细胞增殖和凋亡的影响 被引量:4

Effect of lncRNA EGFR-AS1 Targeting miR-577 on the Proliferation and Apoptosis of Ovarian Cancer Cells
下载PDF
导出
摘要 目的:研究长链非编码RNA(lncRNA)EGFR-AS1对微小RNA-577(miR-577)的靶向关系及对卵巢癌细胞增殖和凋亡的影响。方法:实时荧光定量PCR(q PCR)检测卵巢癌组织中lncRNA EGFR-AS1和miR-577表达。Lnc Base Predicted v.2预测和双荧光素酶报告实验分析lncRNA EGFR-AS1与miR-577的靶向关系。卵巢癌细胞SKOV3中转染si-EGFR-AS1或miR-577,噻唑蓝(MTT)和流式细胞术分别检测细胞增殖与凋亡,蛋白质印迹法(Western blot)检测细胞周期蛋白D1(Cyclin D1)、p21、B细胞淋巴瘤/白血病-2(Bcl-2)、Bcl-2相关X蛋白(Bax)表达。si-EGFR-AS1和anti-miR-577共转染,观察抑制miR-577表达在干扰lncRNA EGFR-AS1表达诱导的SKOV3细胞增殖和凋亡中的作用。结果:卵巢癌组织中lncRNA EGFR-AS1表达量显著高于癌旁组织,miR-577表达量显著低于癌旁组织(P<0.01)。lncRNA EGFR-AS1与miR-577具有靶向结合位点,转染miR-577的WT-EGFR-AS1细胞荧光素酶相对活性显著低于转染miR-NC组(P<0.01)。干扰lncRNA EGFR-AS1表达明显降低SKOV3细胞24,48,72 h的吸光度(A)值及Cyclin D1、Bcl-2蛋白表达量,显著增加细胞凋亡率及p21、Bax蛋白水平(P<0.05或P<0.01)。miR-577过表达显著降低SKOV3细胞48和72 h的A值及Cyclin D1、Bcl-2蛋白水平,显著提高细胞凋亡率及p21、Bax蛋白表达量(P<0.05)。与si-EGFR-AS1和anti-miR-NC共转染比较,si-EGFR-AS1和anti-miR-577共转染显著减少SKOV3的细胞凋亡率及p21、Bax蛋白表达量,显著提高24,48,72 h的A值及Cyclin D1、Bcl-2蛋白水平(P<0.05)。结论:lncRNA EGFR-AS1在卵巢癌中表达上调,干扰lncRNA EGFR-AS1表达可抑制卵巢癌细胞增殖,并诱导凋亡,其作用机制与靶向调控miR-577表达有关。 Objective: To investigate the targeting relationship of lncRNA EGFR-AS1 to miR-577 and its effects on the proliferation and apoptosis of ovarian cancer cells. Methods: q PCR was used to detect the expressions of lncRNA EGFR-AS1 and miR-577 in ovarian cancer tissues. The Lnc Base Predicted v.2 prediction and dual luciferase reporter assays analyzed the targeting relationship between lncRNA EGFR-AS1 and miR-577. Ovarian cancer cell SKOV3 was transfected with si-EGFR-AS1 or miR-577. MTT and flow cytometry was used to detect the cell proliferation and apoptosis,respectively. Western blot was used to detect Cyclin D1,p21,Bcl-2 and Bax expressions. Si-EGFR-AS1 and anti-miR-577 were co-transfected to observe the inhibition role of miR-577 expression in the proliferation and apoptosis of SKOV3 cells induced by lncRNA EGFR-AS1 expression. Results: The expression of lncRNA EGFR-AS1 in ovarian cancer tissue was significantly higher than that in the adjacent tissues,and the expression of miR-577 was significantly lower than that in the adjacent tissues( P<0.01). lncRNA EGFR-AS1 and miR-577 had targeted binding sites. The relative luciferase activity of WT-EGFR-AS1 cells transfected with miR-577 was significantly lower than that of the miR-NC group( P<0.01). Interfering with lncRNA EGFR-AS1 expression significantly reduced the absorbance( A) value at 24,48 and 72 h,Cyclin D1 and Bcl-2 protein expression of SKOV3 cells,and significantly increased the apoptosis rate and the levels of p21 and Bax proteins( P<0.05 or P<0.01). The overexpression of miR-577 significantly reduced the A value at 48 h and 72 h,Cyclin D1 and Bcl-2 protein levels of SKOV3 cells,and significantly increased the apoptosis rate and the expression of p21 and Bax proteins( P<0.05). Compared with co-transfection with siEGFR-AS1 and anti-miR-NC,co-transfection with si-EGFR-AS1 and anti-miR-577 significantly reduced the apoptosis rate,and the protein expressions of p21 and Bax of SKOV3 cells,significantly increased the A at 24,48 and 72 h,and the protein expressions of Cyclin D1 and Bcl-2( P<0.05). Conclusion: lncRNA EGFR-AS1 is up-regulated in ovarian cancer,and interference with lncRNA EGFR-AS1 expression inhibits the proliferation and induces the apoptosis of ovarian cancer cells,and its mechanism is related to targeted regulation of miR-577 expression.
作者 刘凤环 Liu Fenghuan(Department of Obstetrics,Peony People’s Hospital of Heze City,Shandong Heze 274000,China)
出处 《中国药师》 CAS 2020年第12期2378-2383,共6页 China Pharmacist
关键词 lncRNA EGFR-AS1 miR-577 卵巢癌 增殖 凋亡 lncRNA EGFR-AS1 miR-577 Ovarian cancer Proliferation Apoptosis
  • 相关文献

参考文献4

二级参考文献31

  • 1Alessandro Federico,Michele Orditura,Gaetano Cotticelli,Ilario De Sio,Marco Romano,Antonietta Gravina,Marcello Dallio,Alessio Fabozzi,Fortunato Ciardiello,Carmela Loguercio,Ferdinando De Vita.Safety and efficacy of sorafenib in patients with advanced hepatocellularcarcinoma and Child-Pugh A or B cirrhosis[J]. Oncology Letters . 2015 (4)
  • 2Chong Chen,Huan-Xin Zhang,Man Wang,Xuguang Song,Jiang Cao,Lin Wang,Jian-Lin Qiao,Xiao-Yun Lu,Zheng-Xiang Han,Ping Zhu,Bin Pan,Qing-Yun Wu,Kai Zhao,Zhi-Ling Yan,Zhen-Yu Li,Ling-Yu Zeng,Kai-Lin Xu.Stromal cells attenuate the cytotoxicity of imatinib on Philadelphia chromosome-positive leukemia cells by up-regulating the VE-cadherin/β-catenin signal[J]. Leukemia Research . 2014
  • 3Kangsheng Tu,Chao Li,Xin Zheng,Wei Yang,Yingmin Yao,Qingguang Liu.Prognostic significance of miR-218 in human hepatocellular carcinomaand its role in cell growth[J]. Oncology Reports . 2014 (4)
  • 4Yuan X,He J,Sun F, et al.Effects and interactions of MiR-577and TSGA10in regulatingesophageal squamous cell carcinoma. Int J Clin Exp Pathol . 2013
  • 5Gao Jing,Xie Li,Yang Wan-Shui,Zhang Wei,Gao Shan,Wang Jing,Xiang Yong-Bing.Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pacific journal of cancer prevention : APJCP . 2012
  • 6Ali Nermin,Yoshizumi Masanori,Yano Seiji,Sone Saburo,Ohnishi Hideki,Ishizawa Keisuke,Kanematsu Yasuhisa,Tsuchiya Koichiro,Tamaki Toshiaki.The novel Src kinase inhibitor M475271 inhibits VEGF-induced vascular endothelial-cadherin and beta-catenin phosphorylation but increases their association. Journal of pharmacological sciences . 2006
  • 7Chang Y-M,Bai L,Liu S,Yang J C,Kung H-J,Evans C P.Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncegene . 2008
  • 8Vultur Adina,Buettner Ralf,Kowolik Claudia,Liang Wei,Smith David,Boschelli Frank,Jove Richard.SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Molecular Cancer . 2008
  • 9Su C H,Lin Y,Cai L.Genetic factors, viral infection, other factorsand liver cancer: an update on current progress. Asian Pac J CancerPrev . 2013
  • 10Tu K,Zheng X,Dou C,et al.microRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma. Int J Mol Sci . 2014

共引文献124

同被引文献54

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部